Terms: = Sarcomas AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
18 results:
1. Disparities in Survival and NCCN Guideline-Concordant Care in Patients With Extremity Soft Tissue Sarcoma.
Dunlop HM; Bende B; Ruff SM; Kim A; Fisher JL; Grignol VP; Contreras CM; Obeng-Gyasi S; Konieczkowski DJ; Pawlik TM; Pollock RE; Beane JD
J Natl Compr Canc Netw; 2024 Feb; 22(1):26-33. PubMed ID: 38394772
[TBL] [Abstract] [Full Text] [Related]
2. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
3. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience.
Zamarud A; Park DJ; Dadey DYA; Yoo KH; Marianayagam NJ; Yener U; Szalkowski GA; Pollom E; Soltys S; Chang SD; Meola A
Neurosurg Focus; 2023 Aug; 55(2):E7. PubMed ID: 37527671
[TBL] [Abstract] [Full Text] [Related]
4. Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Serrano C; Bauer S; Gómez-Peregrina D; Kang YK; Jones RL; Rutkowski P; Mir O; Heinrich MC; Tap WD; Newberry K; Grassian A; Shi H; Bialick S; Schöffski P; Pantaleo MA; von Mehren M; Trent JC; George S
Ann Oncol; 2023 Jul; 34(7):615-625. PubMed ID: 37105265
[TBL] [Abstract] [Full Text] [Related]
5. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
[TBL] [Abstract] [Full Text] [Related]
6. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
Yoshino K; Kurita T; Takahashi F; Nagase S;
J Obstet Gynaecol Res; 2022 Jul; 48(7):1570-1579. PubMed ID: 35633031
[TBL] [Abstract] [Full Text] [Related]
7. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
[TBL] [Abstract] [Full Text] [Related]
8. Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma.
Sato Y; Nakano K; Fukuda N; Wang X; Urasaki T; Ohmoto A; Yunokawa M; Ono M; Tomomatsu J; Hayakawa K; Funauchi Y; Tanizawa T; Ae K; Matsumoto S; Takahashi S
Anticancer Res; 2021 Jan; 41(1):527-532. PubMed ID: 33419852
[TBL] [Abstract] [Full Text] [Related]
9. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract] [Full Text] [Related]
10. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
Wendt R; Gao Y; Miller BJ
Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
[TBL] [Abstract] [Full Text] [Related]
11. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.
Xie L; Xu J; Sun X; Tang X; Yan T; Yang R; Guo W
Oncologist; 2019 Jul; 24(7):e542-e550. PubMed ID: 30559126
[TBL] [Abstract] [Full Text] [Related]
12. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
Ludwin A; Gawron I; Pityński K
Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
[TBL] [Abstract] [Full Text] [Related]
13. Does a less intensive surveillance protocol affect the survival of patients after treatment of a sarcoma of the limb? updated results of the randomized TOSS study.
Puri A; Ranganathan P; Gulia A; Crasto S; Hawaldar R; Badwe RA
Bone Joint J; 2018 Feb; 100-B(2):262-268. PubMed ID: 29437071
[TBL] [Abstract] [Full Text] [Related]
14. The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Weidhaas JB; Harris J; Schaue D; Chen AM; Chin R; Axelrod R; El-Naggar AK; Singh AK; Galloway TJ; Raben D; Wang D; Matthiesen C; Avizonis VN; Manon RR; Yumen O; Nguyen-Tan PF; Trotti A; Skinner H; Zhang Q; Ferris RL; Sidransky D; Chung CH
JAMA Oncol; 2017 Apr; 3(4):483-491. PubMed ID: 28006059
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of multidrug‑resistant osteosarcoma sublines and the molecular mechanisms of resistance.
Yang JZ; Ma SR; Rong XL; Zhu MJ; Ji QY; Meng LJ; Gao YY; Yang YD; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3269-76. PubMed ID: 27498972
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical analysis of diagnosis and treatment for retroperitoneal malignant fibrous histiocytoma].
Sun C; Li P; Zhang N; Lu C; Huang X; Liu N
Zhonghua Yi Xue Za Zhi; 2015 Jul; 95(26):2090-2. PubMed ID: 26710872
[TBL] [Abstract] [Full Text] [Related]
17. Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience.
Weber DC; Rutz HP; Bolsi A; Pedroni E; Coray A; Jermann M; Lomax AJ; Hug EB; Goitein G
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):865-71. PubMed ID: 17606333
[TBL] [Abstract] [Full Text] [Related]
18. [Ten-year record of surgical treatment of gynaecological carcinomas at Kaiser-Franz-Josef Hospital (author's transl)].
Grünberger V; Hoffelner L; Huber J
Zentralbl Gynakol; 1980; 102(21):1230-9. PubMed ID: 7211024
[TBL] [Abstract] [Full Text] [Related]
